drugset / Trial / NCT03690947
Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate if combination of intravitreal ranibizumab with micropulse laser shows non inferiority compared to intravitreal ranibizumab only in diabetic macular edema.
Timeline
- Start
- 2018-10-01
- Primary completion
- 2021-08-31
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | — | Intravitreal |